Fertility biobanks

Fertility preservation is the effort to help cancer patients retain their fertility, or ability to procreate. Research into how cancer affects reproductive health and preservation options are growing, sparked in part by the increase in the survival rate of cancer patients. The main methods of fertility preservation are ovarian protection by GnRH agonists, cryopreservation of ovarian tissue, eggs or sperm, or of embryos after in vitro fertilization. The patient may also choose to use egg or sperm from a donor by third party reproduction rather than having biological children.

ART World Congress Symposium on Safe and Efficient IVF New York City, USA, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida, USA, World Conference on Regenerative Medicine 2015 Leipzig, Germany, ESBB conference Johannesburg, South Africa, World Conference on Regenerative Medicine 2015 Leipzig Germany, Keystone Stem Cells and Regeneration in the Digestive Organs (X6) Keystone, Colorado, USA, Molecular and Cellular Basis of Growth and Regeneration (A3) Breckenridge, Colorado, USA, Keystone Cardiac Development, Regeneration and Repair (Z2) Snowbird, Utah, USA, Tissue Niches & Resident Stem Cells in Adult Epithelia Gordon Research Conference Hong Kong, China.

According to estimates from the World Bank, global healthcare spending increased at a CAGR of 6.97% from 2003 to 2013, from USD 3,786 Billion in 2003 to USD 7,427 Billion in 2013. In this period, public healthcare spending increased at a CAGR of 7.28%, from USD 2,198 Billion in 2003 to USD 4,440 Billion in 2013. This high growth rate, along with the substantial size of healthcare spending, will act as an important driver for biobanks, hospitals and gene banks, which are the major end-user segments of the biopreservation media & equipment market.

Fertility Biobanks contains thousands of specimens and related data from pregnant women, their infants and partners for future use. These biobank collect different types of sample like Maternal samples such as blood (serum and plasma), vaginal swabs and urine are collected from women during each trimester. Delivery specimens such as placenta, cord blood (serum and plasma), blood, urine, vaginal swabs and amniotic fluid are obtained at labor and delivery. IVF samples provided by patients include follicular fluid samples and blood.

  • New advances in male fertility preservation
  • Embryo, Sperm, Oocyte Storage
  • Fertility, tissue and organ preservation
  • In vitro Fertilization (IVF) Therapy
  • Fertility Biobank for Future Research

Related Conference of Fertility biobanks

February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
June 28-30 2020

Stroke Summit 2020

July 15-16, 2020

12th World Congress and Expo on Stem Cell Research

Prague, Czech Republic
July 15-16, 2020

25th World Biotechnology Congress

London, UK
September 21-22, 2020

14th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
September 23-24, 2020

24th European Biotechnology Congress

Berlin, Germany
October 19-20, 2020

7th Asia Pacific Geriatrics and Gerontology Congress

Tokyo, Japan
October 23-24, 2020

2nd International Conference on Biomarkers and Cancer Targets

Cape Town, South Africa
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07- 08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 14-15, 2020

New frontiers in Genetics Research & Advanced Techniques

San Antonio, USA

Fertility biobanks Conference Speakers

Recommended Sessions

Related Journals

Are you interested in